Huxley SANSA Home Sleep Apnea Test (1000-00) vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Huxley SANSA Home Sleep Apnea Test (1000-00)

by Huxley Medical

iCAC Device

by Bunkerhill Health

AI Verdict

Tool A is designed for diagnosing sleep apnea and cardiac arrhythmias through multi-day physiological monitoring via a wearable patch. In contrast, Tool B utilizes AI to detect and quantify coronary artery calcium from routine chest CT scans for early cardiovascular disease risk assessment. While both leverage AI in cardiology, they address distinct clinical needs and utilize different data sources and methodologies.

Choose Huxley SANSA Home Sleep Apnea Test (1000-00) if…

Choose Huxley SANSA if you require a convenient, app-free, and cellular-enabled home sleep apnea and cardiac arrhythmia diagnostic solution for patients. Its wearable patch design and multi-day monitoring capabilities are ideal for streamlining remote patient care and obtaining comprehensive physiological data without extensive patient interaction.

View Huxley SANSA Home Sleep Apnea Test (1000-00) →

Choose iCAC Device if…

Choose Bunkerhill Health's iCAC Device if your primary objective is to opportunistically detect and quantify coronary artery calcium from routine, non-contrast, non-gated chest CT scans. This AI algorithm is best suited for radiology and cardiology departments aiming to leverage existing imaging data for early cardiovascular disease risk assessment and to provide adjunctive information to radiologists.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Huxley SANSA Home Sleep Apnea Test (1000-00)	iCAC Device
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud-based algorithm with cellular data upload from device	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
BAA Available	Yes AI-estimated	Unknown
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Huxley SANSA Home Sleep Apnea Test (1000-00)

Tool A offers superior patient usability with its app-free, wearable chest patch design and built-in cellular data upload, significantly streamlining the home testing experience. This approach minimizes patient burden and enhances compliance by removing the need for smartphone apps or manual data transfer. Tool B focuses on clinician workflow integration, which is valuable, but Tool A's patient-centric design addresses a broader set of usability challenges for a diagnostic device.

Clinical Value

Tie

Both tools provide significant clinical value through FDA-cleared AI solutions addressing critical health concerns. Tool A offers direct diagnosis for home sleep apnea and cardiac arrhythmias with multi-day monitoring and PSG validation. Tool B provides opportunistic screening for coronary artery calcium from routine CT scans, enabling early cardiovascular disease detection. Their distinct applications offer comparable high impact in improving patient outcomes.

Pricing & Value

Tie

Both Tool A and Tool B state 'contact for pricing' and do not provide any public pricing details or specific information regarding their value proposition beyond clinical benefits. Without transparent pricing or detailed cost-effectiveness analyses, it is impossible to conduct a head-to-head comparison on this dimension.

Enterprise Readiness

iCAC Device

Tool B demonstrates stronger enterprise readiness through its explicit integration capabilities with PACS and EHRs via the Carebricks platform, which are essential for seamless adoption in hospital radiology and cardiology workflows. Furthermore, Bunkerhill Health's 'Trust Center' with SOC 2 Type II Report and ISO 27001:2022 Certificate indicates a robust commitment to security and compliance frameworks critical for large-scale deployments. Tool A confirms HIPAA and BAA compliance but lacks explicit details on broader system integrations.

Innovation

Tie

Both tools showcase significant innovation in their respective domains. Tool A's app-free, cellular-enabled, multi-day, multi-channel wearable for home diagnosis of sleep apnea and cardiac arrhythmias simplifies patient experience and data collection. Tool B innovates by leveraging existing, routine CT scans for opportunistic screening of coronary artery calcium, transforming standard imaging into a powerful tool for early cardiovascular disease detection.

Support & Docs

Huxley SANSA Home Sleep Apnea Test (1000-00)

Tool A explicitly details comprehensive support options, including a customer service phone number, online support, and '24/7 live support' for the SANSA device, along with user manuals. Tool B offers general contact information and mentions providing 'effective customer service' but does not specify the same level of detailed product-specific user support or readily available documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Huxley SANSA Home Sleep Apnea Test (1000-00)	iCAC Device
Tool Name	Huxley SANSA Home Sleep Apnea Test (1000-00)	iCAC Device
Primary Purpose	FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis	FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans
Data Source/Input	Wearable chest patch (9 physiological data channels: ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, Sleep/Wake Staging)	Routine, non-contrast, non-gated chest CT scans
Key Output/Analysis	AI-powered auto-scoring algorithms, multi-day monitoring capability, validated against polysomnography (PSG)	Estimates presence and quantity of coronary artery calcium (CAC), visual representation of estimated CAC segmentation, exact and four-category quantitative estimates of CAC burden in Agatston units
Specialties	Cardiology, Pulmonology, Sleep Medicine	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Huxley SANSA Home Sleep Apnea Test (1000-00) and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does Huxley SANSA's app-free, cellular-enabled wearable patch streamline the diagnostic workflow for home sleep apnea and cardiac arrhythmias for both patients and clinicians?

Huxley SANSA simplifies the diagnostic process by eliminating the need for a patient app and enabling direct cellular data upload from the wearable patch. This reduces patient burden and streamlines data collection for clinicians, allowing for efficient multi-day monitoring without complex setup.

What is the depth of EHR integration offered by the iCAC Device through the Carebricks platform, and how does it facilitate the incorporation of CAC findings into a patient's medical record?

The iCAC Device integrates with EHRs via the Carebricks platform, allowing for seamless incorporation of estimated CAC segmentation and quantitative burden into patient records. This enables physicians to easily access and utilize critical cardiovascular risk information derived from routine CT scans for clinical decision-making.

How does Huxley SANSA's AI-powered auto-scoring and multi-day monitoring compare in diagnostic accuracy and sensitivity to traditional in-lab polysomnography for sleep apnea and arrhythmia detection?

Huxley SANSA is validated against polysomnography (PSG) and demonstrates robust diagnostic performance for OSA detection, with an 88% sensitivity and 87% specificity for moderate-to-severe OSA. Its multi-day monitoring across nine physiological data channels, including ECG, provides comprehensive assessment for both sleep apnea and cardiac arrhythmias.

In what specific clinical scenarios or patient populations would the opportunistic identification and quantification of coronary artery calcium by the iCAC Device be most impactful for early cardiovascular disease detection and risk stratification?

The iCAC Device is most impactful for opportunistically identifying CAC from existing, routine non-contrast, non-gated chest CT scans, particularly in patients undergoing scans for other indications like lung cancer screening. This allows for early detection of cardiovascular disease risk in a broad patient population without requiring additional imaging or radiation exposure, aiding in proactive disease management.

What is the expected learning curve for a physician's office staff to manage Huxley SANSA devices, initiate studies, and interpret the AI-generated reports, and what is the typical time-to-value for integrating this solution?

Given its comfortable, non-invasive wearable patch design and app-free workflow with built-in cellular data upload, the learning curve for staff to manage Huxley SANSA devices and initiate studies is designed to be minimal. This streamlined process, coupled with AI-powered auto-scoring, contributes to a rapid time-to-value by quickly providing diagnostic reports for physician review and interpretation.

What audit-trail capabilities are available with both Huxley SANSA and the iCAC Device to track data access, algorithm interpretations, and overall system usage for compliance and quality assurance?

The iCAC Device explicitly lists 'Audit logs' as a feature, indicating capabilities for tracking system usage and data access. For Huxley SANSA, while not explicitly detailed, its cloud-based algorithm and software portal for clinician review suggest that audit-trail features would be part of its compliance and quality assurance framework.